The role of antiparasitc drugs and steroids in Covid-19 treatment

Authors

DOI:

https://doi.org/10.33448/rsd-v10i8.17300

Keywords:

Ivermectin; Invertebrates; Chloroquine; Nitazoxanide; Glucocorticoids; COVID-19 vaccine; SARS virus; coronavirus infections.

Abstract

Background: COVID-19 has emerged as a pandemic that spread throughout the world in less than 6 months, leaving hundred thousand deaths behind. Surprisingly, old drug arsenal has now been applied as an option of treatment. Objective: The aim of this article was to accomplish a literature review concerning the antiparasitic chloroquine, ivermectin, nitazoxanide; as well as glucocorticoids as possible therapeutic agents to be applied in patients with COVID-19 in Brazilian hospitals. Methodology: clinical evidence of COVID-infected patients and literature consultation have been used for the construction of this article. On line searches and gray literature have also been consulted, whose database include PUBMED Central, BVS/BIREME, Web of Science, Science Direct, Higher Level Personnel Improvement Coordinator (CAPES), Periodic Door (Portal de Periódicos da CAPES, The Cochrane Library and PROSPERO). Results: chloroquine, ivermectin and nitazoxanide present antiviral characteristics to support their usage in phase 1 of COVID-19 symptoms. Glucocorticoids such as methylprednisolone and dexamethasone seem to be more efficient in patients with pulmonary symptoms such as those in phase 2B and 3. Conclusion: According to the articles raised in this review, antiparasitic agents are promising for patients with COVID-19 in the very beginning of the symptoms. Methylprednisolone and dexamethasone are best indicated for hospitalized patients with pulmonary commitment.

Author Biography

Gabriel Henrique Queiroz Oliveira, Faculdade de Odontologia do Recife

Gabriel Henrique Queiroz, 5th year student from Faculdade de Odontologia do Recife (FOR).He intend to do master degree at Universidade de Pernambuco (UPE) and postgraduation at São Leopoldo Mandic. Participates at Projeto de Extensão at FOR, endodontics teaching assistant at FOR, Joined at Liga Odontológica Professor Lauro Soares Bezerra.Enjoys dentistry surgery.

References

Aceto T, Beckhorn G D, Jorgensen J R, & et al. (1966). Iatrogenic ACTH-cortisol insufficiency. Pediatr Clin North Am. 1966;13:543–557.doi: https://doi.org/10.1016/S0031-3955(16)31850-8

Aslangul E, & Le Jeunne C. (2012). [Eye and corticosteroid’s use]. Presse Med. 2012;41:414–421.; doi: 10.1016/j.lpm.2012.02.001 ; PMID: 22377461

Baishanbo A, Gargala G, Duclos C, Françoes A, Rassignol J F, Ballet J J, & Favennec L (2006). Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model. J. Antimicrobe Chemother 57(2); 353-355.doi: https://doi.org/10.1002/acr.20295

Belardo, G., La Frazia, S., Cenciarelli, O., Carta, S., Rossignol, J. F., Santoro, M.G., 2011. Boussinesq M, Gardon J, Gardon-Wendel N, & Chippaux J P, (2003). Clinical picture, epidemiology, and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001;3:17–21. Filaria Journal 2003, 2(Suppl 1):S4 This article is available from: http://filariajournal.com/content/2/S1/S4

Brown E S, & Chandler P A. (2001). Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001;3:17–21.doi: 10.4088/pcc.v03n0104;PMCID: PMC181154;PMID: 15014624

Burg, R. W. & et al. (1979).Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob. Agents Ch. 15, 361–367 (1979).doi: https://doi.org/10.1128/AAC.15.3.361

Calya L, Drucea D. J, Cattona M, Jansb D, & Wagstaffb K M. (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivirus Research 178 (2020) 104787.doi: https://doi.org/10.1016/j.antiviral.2020.104787

Cao, J.; Forrest, J C& Zhang X. A (2015). screen of the NIH collection small molecule library identifies potential coronavirus Antiviral Res, 114 (2015), pp. 1-10doi:https://doi.org/10.1016/j.antiviral.2014.11.010

Carvalho, G. G. P. de; Pires, A. J. V. ; Garcia, R. ; Veloso, C. M. ; Silva, R. R. ;Mendes, F. B. L. ; Pinheiro, A. A. ; & Souza, D. R. de, (2009). In situ degradability of dry matter, crude protein and fibrous fraction of concentrate and agroindustrial by-products. Ciência Anim. Bras., 10 (3): 689-697 Journal article : Ciência Animal Brasileira 2009 Vol.10 No.3 pp.689-697 ref.23 ISSN : 1518-2797

Cavier, R., & Rossignol, J.F., (1982). Etude de diverses associations d’anthelminthiques chez la souris. Rev. Méd. Vét. 133, 779–783. Cosman F, de Beur SJ, LeBoff MS, & et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25:2359–2381.;doi: 10.1007/s00198-014-2794-2

Chaccour C J, Kobylinski K C, Bassat Q, & et al. (2013). Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J 2013; 12: 153.;doi:10.1186/1475-2875-12-153

Chaccour et al.: (2013) Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malaria Journal 2013 12:153 Czock D, Keller F, Rasche FM, & H€aussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44:61-98;doi:https://doi.org/10.2165/00003088-200544010-00003

Dubois E L. (1978). Antimalarials in the management of discoid and systemic lupus arythematosus. Semin Arthritis Rheum. 1978;8:33-51.;doi: : https://doi.org/10.1016/0049-0172(78)90033-1

Ericson-Neilsen W, & Kaye A D. (2014). Steroids: pharmacology, complications, and practice delivery issues. Ochsner J. 2014;14:203–207. Fern,

Euzeby, J.; Prom, T S.& Rossignol. J. F. (1980). Experimentation des propriétés anthelminthiques de la nitazoxanide chez le chien, le chat et les ovins.Rev. Méd. Vét., 131, 687-696.View Record in Scopus Google Scholar

Finegold, S.M., Molitoris, D., Vaisanen, & M.L., (2009). Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora. Antimicrob. Agents Chemother. 53, 281–286.;doi: https://doi.org/10.1128/AAC.00441-08

Freeman, J., Baines, S.D., Todhunter, S.L., Huscroft, G.S., & Wilcox, M.H., (2011). Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole. J. Antimicrob. Chemother. 66, 1407–1408;doi:https://doi.org/10.1093/jac/dkr077

Frieman, M., & et al., 2007. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J. Virol. 81 (18), 9812–9824.;doi:https://doi.org/10.1128/JVI.01012-07

Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamguo J, Chippaux J P, & Boussinesq M, (1997). Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa Loa infections. Lancet 350: 18–22. [PubMed] [Google Scholar]

Gisselmann G., Pusch H., Hovemann B. T., & Hatt H. (2002) Two cDNAs coding for histamine-gated ion channels in D. melanogaster. Nat. Neurosci. 5, 11–12 [PubMed] [Google Scholar].doi:https://doi.org/10.1038/nn787

Gotz, V., & et al., (2016). Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import. Sci. Rep. 6, 23138.;doi:https://doi.org/10.1038/srep23138

Gubareva, L.V., Marjuki, H., Mishin, V. P., Sleeman, K., Tamura, D., & Chesnokov, A., La Cruz, J., Villaneuva, J., Davis, T., (2014). Susceptibility of avian influenza A(H7N9) viruses to FDA approved and investigational antiviral drugs. Programme & Abstract Book, Influenza and Other Respiratory Virus Infections: Advances in Clinical Management. Third ISIRV-Antiviral Group Conference. Abstract P57, 83.

Haffizulla J., Hartman A., & Hoppers M. (2014). Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial. Lancet Infect Dis. 2014;14(7):609–618. 10.1016/s1473-3099(14)70717-0. [published Online First: 2014/05/24]

Hecht D W, Galang M A, Sambol S P, Osmolski J R, Johnson S, & Gerding D N. (2007). In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004, Antimicrob Agents Chemother, 2007, vol. 51 (pg. 2716-9).doi:https://doi.org/10.1128/AAC.01623-06

Hench P S, Kendall E C, Slocumb C H, & et al. (1950). Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever, and certain other conditions. Arch Intern Med (Chic).1950;85:545–666.doi:10.1001/archinte.1950.00230100002001

Hench P S, Kendall E C, Slocumb C H, & et al. (1949). The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin Proc. 1949;24:181–197. 2.

Hiscox, J.A., & et al., (2001). The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus. J. Virol. 75 (1), 506–512.doi:https://doi.org/10.1128/JVI.75.1.506-512.2001

Huscher D, Thiele K, Gromnica-Ihle E, & et al. (2009). Dose-related patterns of glucocorticoid- induced side effects. Ann Rheum Dis. 2009;68:1119–1124.doi:http://dx.doi.org/10.1136/ard.2008.092163

James E R. (2007). The etiology of steroid cataract. J Ocul Pharmacol Ther. 2007;23:403–420.doi:https://doi.org/10.1089/jop.2006.0067

Jefferies, & William McK (2004). Safe uses of cortisol. Springfield, Ill: Charles C. Thomas. ISBN 978-0-398-07500-2. Ketkar, H., & et al., 2019. Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system. Diagn. Microbiol. Infect. Dis. 95 (1), 38–40.

Kamiyama N, Soma R, Hidano S, Watanabe K, Umekita H, Fukuda C, Noguchi K, et al. (2019). Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ... Ketkar H, Yang L, Wormser GP, Wang P. Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system. Diagn Microbiol Infect Dis. 2019;95(1):38–40 . doi:https://doi.org/10.1016/j.compbiolchem. 2017.10.011.

Ken (2010–2020). & quot;Cinchona officinalis – L." Plans for a Future. Archived from the original on 25 August 2017. Retrieved 2 February 2020. Fel A,

Krafts K, Hempelmann E, & Skórska-Stania A (July 2012). "From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy". Parasitology Research. 111 (1): 1–6.

Li, J; Bao, Z; Zhuang, D; Liu, S: Liu, Y & ZhangInactivation, W. (2003). efficacy on new coronavirus of a compound disinfecting nanoemulsion Chin. J. Disinfection, 20 (2003), pp. 116-117 [in Chinese].

Mosholder, A D; Mathew, J.; Alexander, J J; Smith, H & Nambiar, S. (2013). “Cardiovascular risks with azithromycin and other antibacterial drugs,” The New England Journal of Medicine, 368(18), 1665–1668, 2013.

Mandeep R, Mehra, Sapan S Desai, Frank Ruschitzka, & Amit N Patel. (2020). Hydroxychloroquineor chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. May 22, 2020.doi:https://doi.org/10.1016/S0140-6736(20)31180-6.

McGavock J M, Lingvay I, Zib I, & et al. (2007)Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation. 2007;116:1170–1175.

Meshnick S R, Dobson M J. ... Rainsford K D, Parke A L, Clifford-Rashotte M, Kean W F. (2015). Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, ... Inflammopharmacology (2015)23(5):231–69. doi:10.1007/s10787-015-0239-y

O’Hare. A. Munro Neville, & Michael J. (1982). The Human Adrenal Cortex Pathology and Biology – An Integrated Approach. Springer London. pp. Chapter 4: Structure of the adult cortex. ISBN 978144711317

Pankuch, G. A. & Appelbaum. P. C. (2006). Postantibiotic effect of ceftobiprole against 12 gram-positive organisms. Antimicrob. Agents Chemother. 50:3956-3958. [PMC free article] [PubMed].doi: 10.1128/AAC.00724-06

Peters, W. (1971). Chemotherapy and drug resistance in malaria. Ipswich, Academic Press, 1970. 876 p. Powell SJ: Therapy of amebiasis. Bull NY Acad Med 47:469-477, 1971

Rainsford K D, Parke A L, Clifford-Rashotte M, & Kean W F. (2010).Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology. 2015;23(5):231-69. mononuclear cells from patients with systemic lupus erythematosus. ... Rheumatology (Oxford) (2010) 49(12):2281–9. doi:10.1093/rheumatology/keq226

Rockwell D A. (1968). Psychiatric complications with chloroquine and quinacrine. Am J Psychiatry.1968;124(9):1257-60.

Rossignol J-F. (2016). Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus. Journal of Infection and Public Health. 2016;9(3):227–230. doi: 10.1016/j.jiph.2016.04.001.

Rossignol J F, La Frazia S, Chiappa L, Ciucci A, & Santoro M G. (2009). Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level. J Biol Chem 2009;284:29798–808.

Rossignol J F, La Frazia S, Chiappa L, Ciucci A, Santoro M G. (2009).Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post- translational level. J Biol Chem. (2009) 284:29798–808. doi: 10.1074/jbc.M109.029470.

Rossignol. J. F. and & H. Malsonneuve (1984). “Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections.” Am J Trop Med Hyg 33 (Copyright (C) 2015 U.S. National Library of Medicine): 511-512.

Rowland, R. R., & et al., (2005). Intracellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein: absence of nucleolar accumulation during infection and after expression as a recombinant protein in vero cells. J. Virol. 79 (17), 11507–11512.doi:https://doi.org/10.1128/JVI.79.17.11507-11512.2005

Santulli G. M D (2015). Adrenal Glands: From Pathophysiology to Clinical Evidence. Nova Science Publishers, New York, NY. ISBN 978-1-63483-570-1.

Savarino A, Boelaert J R, Cassone A, Majori G, & Cauda R (2003). "Effects of chloroquine on viral infections: an old drug against today's diseases?". The Lancet. Infectious Diseases. 3 (11): 722–7.doi:https://doi.org/10.1016/S1473-3099(03)00806-5

Schakman O, Gilson H, & Thissen J P. (2008). Mechanisms of glucocorticoid-induced myopathy. J Endocrinol. 2008;197:1–10.doi: 10.1677/joe-07-0606

Silva J A, Jacobs J W, Kirwan J R, & et al. (2006). Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006;65:285–293.;doi:http://dx.doi.org/10.1136/ard.2005.038638

Sleeman, K., Tamura, D., Chesnokov, A., La Cruz, J., Villaneuva, J.,& Davis, T., (2014). Susceptibility of avian influenza A(H7N9) viruses to FDA approved and investigational antiviral drugs. Programme & Abstract Book, Influenza and Other Respiratory Virus Infections: Advances in Clinical Management. Third ISIRV-Antiviral Group Conference. Abstract P57, 83.

Simmons G, Reeves J D, Rennekamp A J, Amberg, S M, & Piefer A J. Bates P. (2004). Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci. usa 2004. 101 4240-4245.doi:https://doi.org/10.1073/pnas.0306446101

Souverein P C, Berard A, Van Staa T P, & et al. (2004). Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study. Heart.2004;90:859–865.doi:http://dx.doi.org/10.1136/hrt.2003.020180

Smith T, Bushek J, & Prosser T. (2020). COVID-19 Drug therapy – Potential Options. Elsevier, March 26, 2020. Tanaka H, Hirano F, Nomura Y, & et al. Relative glucocorticoid potency revisited. Rheumatol;Int. 1994;14:9-12.doi:https://doi.org/10.1007/BF00302665

Tay, M. Y., & et al., (2013). Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. Antivir. Res. 99 (3),301–306.doi:https://doi.org/10.1016/j.antiviral.2013.06.002

Thomsen E K, Sanuku N, Baea M, & et al. (2016). Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of bancroftian filariasis.Clin Infect Dis 2016; 62: 334–41.doi:https://doi.org/10.1093/cid/civ882

Timani, K.A., & et al., (2005). Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Res. 114 (1–2), 23–34.doi:https://doi.org/10.1016/j.virusres.2005.05.007

Van der Goes M, Jacobs J W, & Bijlsma J W. (2014). The value of glucocorticoid co-therapy in different rheumatic diseases-positive and adverse effects. Arthritis Res Ther. 2014;16 Suppl 2:S2.doi:: https://doi.org/10.1186/ar4686

Van der Hooft C S, Heeringa J, Brusselle G G, & et al. (2006). Corticosteroids and the risk of atrial fibrillation. Arch Intern Med. 2006;166:1016–1020.doi:10.1001/archinte.166.9.1016

Wagstaff, K. M., & et al., (2011). An AlphaScreen(R)-based assay for high-throughput screening for specific inhibitors of nuclear import. J. Biomol. Screen 16 (2), 192–200.doi:https://doi.org/10.1177/1087057110390360

Wallace D J (1994). Antimalarial agents and lupus. Rheum Dis Clin North Am. 1994;20(1): 243-63. Review.doi:https://doi.org/10.1016/S0889-857X(21)00233-7

Weinstein R S. (2012). Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am. 2012;41:595–611.

Whitehead, Saffron A.; Nussey, S. (2001). Endocrinology: an integrated approach.Oxford: BIOS. p. 122. ISBN 978-1-85996-252-7.

Wulan, W. N., & et al., (2015). Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses. Front. Microbiol. 6, 553.doi:https://doi.org/10.3389/fmicb.2015.00553

Wurm, T., & et al., (2001). Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division. J. Virol. 75 (19), 9345–9356.doi:https://doi.org/10.1128/JVI.75.19.9345-9356.2001

Yang, S. N .Y., & et al., (2020). The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta1 heterodimer. Antivir. Res. 104760.doi:https://doi.org/10.1016/j.antiviral.2020.104760

Yoshimura, T.; Matsushima, K.; Tanaka. S. & et al. (1987). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233-9237. 1987.doi:https://doi.org/10.1073/pnas.84.24.9233

Zheng Y., Hirschberg B., Yuan J., Wang A. P., Hunt D. C., Ludmerer S. W., Schmatz D. M., & Cully D. F. (2002) Identification of two novel Drosophila melanogaster histamine-gated chloride;channel subunits expressed in the eye. J. Biol. Chem. 277, 2000–2005 [PubMed] [Google Scholar]doi:https://doi.org/10.1074/jbc.M107635200)

Downloads

Published

14/07/2021

How to Cite

SILVA, L. B.; MELO JUNIOR, P. R. .; SAMPAIO, G. M. .; OLIVEIRA, G. H. Q. .; SILVA, H. F. da; MAIA, S. S. The role of antiparasitc drugs and steroids in Covid-19 treatment. Research, Society and Development, [S. l.], v. 10, n. 8, p. e39510817300, 2021. DOI: 10.33448/rsd-v10i8.17300. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/17300. Acesso em: 20 apr. 2024.

Issue

Vol. 10 No. 8

Section

Health Sciences

License

Copyright (c) 2021 Luciano Barreto Silva; Paulo Reis Melo Junior; Guilherme Marinho Sampaio; Gabriel Henrique Queiroz Oliveira; Hadassa Fonsêca da Silva; Sandra Sayão Maia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.